Health Talks — Vitamin Supplements and Precision Health: Insights and Uses

Vitamin and supplement manufacturing reached almost $40 billion in revenue in 2022, while the nutrigenomics market is expected to grow by over 12% by 2026. How can precision health using nutritional supplements and nutrigenomics improve health outcomes? What are the potential risks associated with the unregulated nature of the supplements market?

Carol Johnston, associate dean and professor; Dorothy Sears, professor and executive director of clinical and community translational science; and moderator Simin Levinson discussed how health professionals can confidently deploy personalized treatment strategies for effective clinical care.

Recorded Thursday, Dec. 8, 2022.
Be the first to comment